The global hysterectomy device market revenue was around US$ 346.4 million in 2022 and is estimated to reach US$ 565.6 million by 2031, growing at a compound annual growth rate (CAGR) of 5.6% during the forecast period from 2023 to 2031.
Hysterectomy devices are medical devices utilized in the surgical removal of the uterus. Hysterectomies are a typical gynecological procedure, and the devices utilized in these procedures can vary depending on the kind of surgery performed. This can be accomplished for a variety of reasons, such as to treat gynecological disorders like endometriosis, uterine fibroids, and abnormal uterine bleeding, or to treat specific types of cancer.
Market Driving Factors
The increasing emphasis on recognizing and meeting precise health needs and worries of women is referred to as the increase in awareness of women's health. There has been a considerable trend in the medical community recently toward recognizing and managing gender-specific health problems. Thus, a surge in awareness about women’s health drives the hysterectomy device market growth.
Technological advancements are estimated to propel the market. Hysterectomy is a less invasive, safer, and more practical treatment for female patients owing to the development of new and enhanced surgical tools and techniques. In addition, open surgery was utilized in conventional hysterectomy treatments, which needed a substantial incision and a lengthy healing period.
The high price of treatment and availability of alternative treatments are estimated to restrain the market growth.
Regional Analysis
North America dominated the market in terms of the largest share and continued its dominance over the forecast period. This is largely attributed to the existence of various major players, such as Jhonson & Jhonson, CooperCompanies, and technological advances in the region. Additionally, the increase in the prevalence of uterine cancer in the region is predicted to drive market growth. Furthermore, the existence of well-established healthcare infrastructure and high purchasing power, and the acquisitions adopted by the essential players in this region drive the market growth.
Asia-Pacific is estimated to dominate the market in terms of the highest rate during the projection period. This is due to the existence of pharmaceutical companies in the region and the growth in the purchasing power of populated nations, such as India and China. Furthermore, this region provides profitable possibilities for key players functioning in the market.
Furthermore, the increasing infrastructure of industries, surging disposable incomes, and well-established existence of domestic companies in the region benefit the market. Moreover, the increase in contract manufacturing organizations within the region offers lucrative opportunities for new entrants in this region.
Segmentation Insights
Surgical Approach Insight
The laparoscopic hysterectomy segment dominates the market in terms of the highest growth rate. This is owing to its surge in preference for open surgery, which provides various benefits. Patients generally suffer leave fewer scars, less pain, and recover more quickly. Furthermore, laparoscopic hysterectomy patients are generally home the same day or require an overnight stay. More minor, shallower incisions result in small to no blood loss and less threat of issues such as abdominal infections.
Disease Type Insight
The fibroids segment dominates the market in terms of the fastest rate. This is because they are extremely prevalent and non-cancerous. Leiomyomas or myomas, often known as uterine fibroids, are changes that grow in the uterus, and the uterine muscle creates them. A massive number of people with uteruses will experience a fibroids diagnosis at some point in their lives.
End User Insight
The hospital segment dominates the market in terms of the largest share. This is due to the provision of diagnosis for disease detection, postoperative care, and preoperative care, making it a one-stop-shop for patients experiencing hysterectomy procedures.
Prominent Companies
Segmentation Outline
The global hysterectomy device market segmentation focuses on Surgical Approach, Disease Type, End User, and Region.
By Surgical Approach
By Disease Type
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL HYSTERECTOMY DEVICE MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: HYSTERECTOMY DEVICE MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL HYSTERECTOMY DEVICE MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL HYSTERECTOMY DEVICE MARKET, BY SURGICAL APPROACH
5.1 OVERVIEW
5.2 LAPAROSCOPIC HYSTERECTOMY
5.3 ROBOTIC-ASSISTED LAPAROSCOPIC HYSTERECTOMY
5.4 ABDOMINAL HYSTERECTOMY
5.5 VAGINAL HYSTERECTOMY
6 GLOBAL HYSTERECTOMY DEVICE MARKET, BY DISEASE TYPE
6.1 OVERVIEW
6.2 UTERINE CANCER
6.3 FIBROIDS
6.4 CHRONIC PELVIC PAIN
6.5 OTHERS
7 GLOBAL HYSTERECTOMY DEVICE MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITALS
7.3 AMBULATORY SURGICAL CENTERS
7.4 OTHERS
8 GLOBAL HYSTERECTOMY DEVICE MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL HYSTERECTOMY DEVICE MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 MEDTRONIC PLC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 CONMED CORPORATION
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 B. BRAUN MELSUNGEN AG
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 FORTIMEDIX SURGICAL B.V.
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 JOHNSON & JOHNSON
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 LABORIE INC
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 RICHARD WOLF GMBH
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 COOPER COMPANIES INC
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 KARL STORZ GMBH & CO. KG
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 CONKIN SURGICAL INSTRUMENTS LTD
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved